Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cosopt Versus Xalatan in Glaucoma and Ocular Hypertension
NCT00273429Phase 4Completed
- Sponsor
- PRN Pharmaceutical Research Network
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dorzolamide + timolol in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by PRN Pharmaceutical Research Network. Primary endpoint: 24-hour Diurnal Intraocular Pressure. Started Apr 2005; status: completed.
02
Drugs
dorzolamide + timolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00273429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273429.